Physician profile
Kurt D Meyer
NPI 1962799452
$12,328.90
in general payments reported to CMS, 2019-2025
76 companies · $2,538 in 2025
The $2,538 reported for 2025 was more than what 91% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,580 · 2020: $408 · 2021: $248 · 2022: $1,799 · 2023: $2,886 · 2024: $2,869 · 2025: $2,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,292.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,063.99 | 2019-2025 | Enhertu, Tagrisso, Calquence |
| Novartis Pharmaceuticals Corporation | $943.78 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $703.17 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Takeda Pharmaceuticals U.S.A., INC. | $620.01 | 2019-2025 | Alunbrig, Fruzaqla, Ninlaro |
| Janssen Biotech, INC. | $599.57 | 2019-2025 | Erleada, Balversa, Akeega |
| Lilly USA, LLC | $415.73 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Daiichi Sankyo INC. | $392.37 | 2019-2025 | Injectafer, Enhertu, Datroway |
| Genentech USA, INC. | $360.19 | 2022-2025 | Tecentriq, Polivy, Lunsumio |
| Bayer Healthcare Pharmaceuticals INC. | $349.60 | 2019-2024 | |
| Pfizer INC. | $326.04 | 2022-2025 | |
| Seagen INC. | $295.78 | 2019-2023 | Tukysa, Adcetris |
| Incyte Corporation | $290.45 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Myovant Sciences INC. | $264.45 | 2021-2022 | |
| Eisai INC. | $249.84 | 2019-2025 | |
| Glaxosmithkline, LLC. | $227.68 | 2022-2025 | Ojjaara, Jemperli, Zejula |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $224.63 | 2019-2024 | Xospata, Padcev, Xtandi |
| Celgene Corporation | $223.85 | 2019-2024 | Reblozyl, Opdualag |
| Emd Serono, INC. | $200.48 | 2023-2025 | Bavencio, Tepmetko |
| Puma Biotechnology, INC. | $179.72 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $176.24 | 2019-2023 | Eliquis |
| Sobi, INC | $174.19 | 2022-2025 | |
| Siemens Medical Solutions USA, INC. | $171.22 | 2023 | |
| Eagle Pharmaceuticals, INC. | $168.09 | 2022-2024 | |
| Rigel Pharmaceuticals, INC. | $156.61 | 2023-2025 | Rezlidhia, Tavalisse, Gavreto |
| Taiho Oncology, INC. | $153.45 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $149.59 | 2022-2025 | Fotivda |
| Sirtex Medical INC | $148.78 | 2019 | |
| Jazz Pharmaceuticals INC. | $144.45 | 2022-2025 | Zepzelca |
| Amgen INC. | $127.64 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $127.28 | 2022-2025 | Xpovio |
| Ipsen Biopharmaceuticals, INC | $124.50 | 2019-2025 | Onivyde, Somatuline Depot |
| Adc Therapeutics America, INC. | $121.87 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $121.75 | 2019-2025 | Libtayo |
| Foundation Medicine, INC. | $114.67 | 2020 | |
| Abbvie INC. | $111.78 | 2024-2025 | |
| Genmab U.S., INC. | $111.64 | 2023-2025 | Tivdak, Epkinly |
| Exelixis INC. | $106.81 | 2023-2025 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $105.15 | 2022-2024 | Ultomiris |
| Spectrum Pharmaceuticals INC. | $101.90 | 2023-2025 | Rolvedon |
| Progenics Pharmaceuticals, INC. | $98.32 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.71 | 2019-2025 | Gilotrif |
| Genzyme Corporation | $90.12 | 2019-2025 | |
| Servier Pharmaceuticals LLC | $89.70 | 2023-2025 | |
| Beigene USA, INC. | $82.12 | 2023-2024 | Brukinsa |
| G1 Therapeutics, INC. | $80.10 | 2022-2023 | Cosela |
| Sumitomo Pharma America, INC. | $79.83 | 2023-2025 | Orgovyx |
| Kyowa Kirin, INC. | $79.19 | 2019-2024 | Poteligeo |
| Immunocore Limited | $71.31 | 2024-2025 | Kimmtrak |
| Array Biopharma INC | $68.69 | 2023-2025 | Mektovi, Braftovi, Xalkori |
| Stemline Therapeutics INC. | $66.64 | 2025 | Orserdu |
| Janssen Pharmaceuticals, INC | $64.51 | 2022-2024 | Xarelto |
| Mirati Therapeutics, INC. | $56.45 | 2023-2024 | Krazati |
| Pharmaessentia USA Corporation | $52.53 | 2024 | Besremi |
| Macrogenics, INC. | $47.43 | 2022-2023 | |
| Morphosys, US INC. | $45.92 | 2022-2023 | Monjuvi |
| Cti Biopharma Corp. | $40.93 | 2022-2023 | Vonjo |
| Deciphera Pharmaceuticals INC. | $40.84 | 2023 | Qinlock |
| Beone Medicines USA, INC. | $38.26 | 2025 | Brukinsa, Tevimbra |
| Dova Pharmaceuticals | $35.36 | 2019-2020 | |
| Springworks Therapeutics, INC. | $29.82 | 2024 | Ogsiveo |
| Gilead Sciences, INC. | $28.90 | 2025 | Trodelvy |
| Helsinn Therapeutics (U.S.), INC. | $26.28 | 2019-2022 | |
| Genentech, INC. | $25.79 | 2024 | Lunsumio, Columvi |
| Blueprint Medicines Corporation | $25.60 | 2022-2023 | Ayvakit |
| Geron Corporation | $23.62 | 2025 | Rytelo |
| Agios Pharmaceuticals, INC. | $23.26 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $22.90 | 2019 | |
| Novocure INC. | $22.75 | 2025 | Optune Lua (Novottf-200t) |
| Aurobindo Pharma USA, INC. | $21.50 | 2019 | |
| Verastem, INC. | $19.77 | 2025 | Avmapki Fakzynja Co-Pack |
| Epizyme, INC. | $17.28 | 2022 | |
| Clovis Oncology, INC. | $16.69 | 2019 | |
| Pharmacosmos Therapeutics INC. | $14.79 | 2023 | Monoferric |
| Coherus Oncology, INC. | $14.31 | 2025 | Loqtorzi |
| Mylan Institutional INC. | $12.57 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
Keytruda $515Enhertu $353Kisqali $337Jaypirca $297Verzenio $282Erleada $230Xofigo $217Nubeqa $217Scemblix $198Orgovyx $171Piqray $162Injectafer $159Tavalisse $157Rezlidhia $157Pemfexy $155Xtandi $152Tagrisso $151Lenvima $136Fotivda $133Zepzelca $121Jakafi $121Lynparza $119Calquence $118Alunbrig $116Padcev $114Retevmo $111Talzenna $109Tecentriq $109Cabometyx $107Ojjaara $106Brukinsa $105Rolvedon $102Polivy $102Inqovi $101Lonsurf $101Monjuvi $96.74Inlyta $95.16Fruzaqla $90.44Libtayo $89.32Tukysa $89.26Venclexta $88.35Xpovio $87.97Ultomiris $87.34Onivyde $86.31Ninlaro $84.23Fabhalta $83.72Lunsumio $83.31Elrexfio $80.11Elahere $79.82Adcetris $77.88Tivdak $75.67Kimmtrak $71.31Mektovi $68.69Orserdu $66.64Somatuline Depot $64.74Balversa $60.55Pemazyre $59.92Gavreto $59.70Iclusig $59.22Zejula $58.41Jemperli $58.41Bavencio $58.17Krazati $56.45Welireg $56.08Braftovi $55.23Poteligeo $55.17Besremi $52.53Voranigo $48.98Xarelto $48.39Vonjo $47.85Xospata $47.47Columvi $46.79Zynlonta $46.56Itovebi $45.58Bosulif $44.28Akeega $41.18Qinlock $40.84Idhifa $40.72Perjeta $38.38Tepmetko $36.87Epkinly $35.97Niktimvo $35.14Exkivity $34.29Reblozyl $33.25Ayvakit $32.85Nerlynx $31.96Promacta $31.94Gilotrif $30.48Lutathera $30.47Ogsiveo $29.82Besponsa $28.96Trodelvy $28.90Rybrevant $28.81Margenza $28.75Sarclisa $27.94Lorbrena $27.25Xalkori $27.25Datroway $26.63Stivarga $23.83Vitrakvi $23.83
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.